Victoza is a type 2 diabetes treatment medication that lowers blood sugar levels and effectively gets Type 2 diabetics down to the 7% or lower A1C test score. Victoza is a GLP-agonist medication that works in 3 ways to regulate blood glucose. By slowing food leaving the stomach, preventing sugar production by the liver, and then promoting more insulin production from the pancreas it is often more effective for blood sugar control for certain people. It may also be a better choice for people with Type 2 diabetes and the risk of cardiovascular events and can be used by children 10 years of age and up. Fact Table Formula C172H265N43O51 License US FDA, EU EMA Bioavailability ~ 55% Legal status Rx-Only Chemical Name Liraglutide Elimination half-life ~ 13 h Dosage (Strength) 6mg/ml (3ml pens) Pregnancy Consult Doctor Brands Victoza Protein binding More than 98% PubChem CID 16134956 MedlinePlus a611003 ChEBI 71193 ATC code A10BJ02 DrugBank DB06655 KEGG D06404 Routes of administration Subcutaneous
Victoza (Liraglutide)
- Use your Victoza pen exactly as indicated in your prescription, and administering only the correct dosage as provided with your pen - either a 0.6mg / 1.2mg / 1.8mg dosage that is administered once a day Inject your self under the skin of your belly, thigh, or upper arm once a day. Do not exceed the dosage guidelines and see your doctor again if you are unable to manage your A1C.
